Inhibrx Biosciences (INBX) Accumulated Depreciation & Amortization: 2023-2025
Historic Accumulated Depreciation & Amortization for Inhibrx Biosciences (INBX) over the last 3 years, with Sep 2025 value amounting to $582,000.
- Inhibrx Biosciences' Accumulated Depreciation & Amortization fell 23.42% to $582,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 37.77%. This contributed to the annual value of $2.3 million for FY2024, which is 91.86% up from last year.
- Inhibrx Biosciences' Accumulated Depreciation & Amortization amounted to $582,000 in Q3 2025, which was down 12.08% from $662,000 recorded in Q2 2025.
- In the past 5 years, Inhibrx Biosciences' Accumulated Depreciation & Amortization ranged from a high of $760,000 in Q3 2024 and a low of $294,000 during Q2 2023.
- Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $528,500 (2024), whereas its average is $509,900.
- As far as peak fluctuations go, Inhibrx Biosciences' Accumulated Depreciation & Amortization surged by 150.00% in 2024, and later fell by 23.42% in 2025.
- Over the past 3 years, Inhibrx Biosciences' Accumulated Depreciation & Amortization (Quarterly) stood at $298,000 in 2023, then spiked by 131.21% to $689,000 in 2024, then dropped by 23.42% to $582,000 in 2025.
- Its last three reported values are $582,000 in Q3 2025, $662,000 for Q2 2025, and $675,000 during Q1 2025.